Related Experiment Video
Updated: Aug 25, 2026

Generation and Culturing of Primary Human Keratinocytes from Adult Skin
Published on: December 22, 2017
Modulation of proliferation-specific and differentiation-specific markers in human keratinocytes by SMAD7
Louise Smith1, Alison L Dahler, Lois L Cavanagh
1Epithelial Pathobiology Group, Cancer Biology Programme, Centre for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Abstract:
We examined the potential role of SMAD7 in human epidermal keratinocyte differentiation. Overexpression of SMAD7 inhibited the activity of the proliferation-specific promoters for the keratin 14 and cdc2 genes and reduced the expression of the mRNA for the proliferation-specific genes cdc2 and E2F1. The ability of SMAD7 to suppress cdc2 promoter activity was lost in transformed keratinocyte cell lines and was mediated by a domain(s) located between aa 195-395 of SMAD7. This domain lies outside the domain required to inhibit TGFbeta1 signaling, suggesting that this activity is mediated by a novel functional domain(s). Examination of AP1, NFkappaB, serum response element, Gli, wnt, and E2F responsive reporters indicated that SMAD7 significantly suppressed the E2F responsive reporter and modestly increased AP1 activity in proliferating keratinocytes. These data suggest that SMAD7 may have a role in TGFbeta-independent signaling events in proliferating/undifferentiated keratinocytes. The effects of SMAD7 in differentiated keratinocytes indicated a more traditional role for SMAD7 as an inhibitor of TGFbeta action. SMAD7 was unable to initiate the expression of differentiation markers but was able to superinduce/derepress differentiation-specific markers and genes in differentiated keratinocytes. This latter role is consistent with the ability of SMAD7 to inhibit TGFbeta-mediated suppression of keratinocyte differentiation and suggest that the opposing actions of SMAD7 and TGFbeta may serve to modulate squamous differentiation.
Insights
SMAD7 plays a dual role in keratinocyte differentiation, inhibiting proliferation in normal cells but promoting differentiation in response to TGF-beta. This suggests SMAD7 modulates squamous differentiation through TGF-beta-dependent and -independent pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Dermatology
Background:
- Human epidermal keratinocyte differentiation is a complex process regulated by various signaling pathways.
- SMAD7 is known to inhibit TGF-beta signaling, a key regulator of keratinocyte differentiation.
Purpose of the Study:
- To investigate the role of SMAD7 in human epidermal keratinocyte differentiation.
- To elucidate the specific mechanisms and signaling pathways involved in SMAD7's function.
Main Methods:
- Overexpression of SMAD7 in human epidermal keratinocytes.
- Analysis of proliferation-specific and differentiation-specific gene expression and promoter activity.
- Examination of various signaling pathway reporters (AP1, NFkappaB, E2F, etc.).
Main Results:
- SMAD7 inhibited proliferation-specific gene promoters (keratin 14, cdc2) and mRNA expression (cdc2, E2F1) in proliferating keratinocytes.
- This inhibitory effect on proliferation was mediated by a novel domain outside the TGF-beta inhibitory region and was lost in transformed cells.
- SMAD7 suppressed E2F-responsive reporters and modestly increased AP1 activity in proliferating cells.
- In differentiated keratinocytes, SMAD7 acted as an inhibitor of TGF-beta, superinducing differentiation markers.
Conclusions:
- SMAD7 exhibits distinct functions in proliferating versus differentiated keratinocytes.
- SMAD7 participates in TGF-beta-independent signaling pathways regulating keratinocyte proliferation.
- SMAD7 modulates squamous differentiation by opposing TGF-beta's suppressive effects.
Related Concept Videos
TGF - β Signaling Pathway
Renewal of Skin Epidermal Stem Cells
Abnormal Proliferation
Inhibition of Cdk Activity
Somatic to iPS Cell Reprogramming

